Allowed
BloodPolicy
Preferred server
Notes
Reference notes
Coverage
57 journals
Sources
Publisher preprint policies (Feb 2026)
Last reviewed
February 2026
Prepared by the Manusights editorial team.
Preprint-policy guide
Preprints have moved from the margins of biomedicine to mainstream practice, accelerated by COVID-19, driven by NIH policy, and now standard practice at most major journals. If you're still unsure whether to post one, or which journals will accept a manuscript after you do, this guide covers both.
Quick orientation
This guide is for the decision stage: whether to post, which server fits the manuscript, what the target journal expects you to disclose, and where the rare exceptions still exist.
Best used with
Author rights guide
Use it when preprint questions turn into accepted-manuscript or copyright questions later in the workflow.
Open access guide
Pair preprint strategy with funder mandates, APC planning, and the final publication route.
Data sharing requirements
Make sure repository and dataset timing decisions stay aligned with the preprint plan.
7
Actively encouraged
49
Allowed
0
Allowed with conditions
1
Not allowed
A preprint is a version of a manuscript posted publicly before peer review. It gets a timestamp and a DOI through a preprint server (bioRxiv for life sciences, medRxiv for clinical/health sciences), making it citable and shareable immediately.
Preprints don't replace peer review, they run alongside it. You post the preprint, then submit to a journal. The journal reviews it independently. If accepted, the preprint stays up alongside the published version.
The NIH now actively encourages preprint posting and has included preprints in its citation pilot on PubMed since 2020. For many researchers, posting to bioRxiv or medRxiv before or during peer review is now standard practice.
Cold Spring Harbor Laboratory. For life sciences broadly: molecular biology, cell biology, genetics, neuroscience, immunology, biochemistry, genomics, evolutionary biology. The default preprint server for most basic research.
biorxiv.org | Free to post
Cold Spring Harbor Laboratory + Yale + BMJ. For health sciences, clinical medicine, epidemiology, public health, and clinical trials. Use medRxiv if your work involves patient data, clinical outcomes, or health policy implications.
medrxiv.org | Free to post | Additional screening for clinical content
Search journals, policy status, preferred preprint servers, and disclosure notes. Export the current view or copy rows into a lab submission guide or publishing policy sheet.
Visible journals
57
Policy statuses
3
medRxiv mentions
27
Allowed
BloodPolicy
Preferred server
Notes
Allowed
BMC MedicinePolicy
Preferred server
Notes
Encouraged
BMJ OpenPolicy
Preferred server
Notes
Allowed
BrainPolicy
Preferred server
Notes
Allowed
Cancer CellPolicy
Preferred server
Notes
Allowed
CellPolicy
Preferred server
Notes
Allowed
Cell Host & MicrobePolicy
Preferred server
Notes
Allowed
Cell MetabolismPolicy
Preferred server
Notes
Allowed
Cell ReportsPolicy
Preferred server
Notes
Allowed
Cell Stem CellPolicy
Preferred server
Notes
Allowed
CirculationPolicy
Preferred server
Notes
Allowed
Circulation ResearchPolicy
Preferred server
Notes
Allowed
Current BiologyPolicy
Preferred server
Notes
Allowed
Developmental CellPolicy
Preferred server
Notes
Encouraged
eLifePolicy
Preferred server
Notes
Allowed
European Heart JournalPolicy
Preferred server
Notes
Allowed
Frontiers in ImmunologyPolicy
Preferred server
Notes
Allowed
GastroenterologyPolicy
Preferred server
Notes
Encouraged
Genome BiologyPolicy
Preferred server
Notes
Allowed
GUTPolicy
Preferred server
Notes
Allowed
HepatologyPolicy
Preferred server
Notes
Allowed
ImmunityPolicy
Preferred server
Notes
Allowed
JACCPolicy
Preferred server
Notes
Allowed
JAMAPolicy
Preferred server
Notes
Allowed
JAMA CardiologyPolicy
Preferred server
Notes
Allowed
JAMA OncologyPolicy
Preferred server
Notes
Not allowed
Journal of Clinical InvestigationPolicy
Preferred server
Notes
Allowed
Journal of Clinical OncologyPolicy
Preferred server
Notes
Allowed
Journal of NeurosciencePolicy
Preferred server
Notes
Allowed
Lancet Infectious DiseasesPolicy
Preferred server
Notes
Allowed
Lancet NeurologyPolicy
Preferred server
Notes
Allowed
Molecular CellPolicy
Preferred server
Notes
Allowed
Molecular PsychiatryPolicy
Preferred server
Notes
Allowed
NaturePolicy
Preferred server
Notes
Allowed
Nature BiotechnologyPolicy
Preferred server
Notes
Allowed
Nature Chemical BiologyPolicy
Preferred server
Notes
Allowed
Nature CommunicationsPolicy
Preferred server
Notes
Allowed
Nature GeneticsPolicy
Preferred server
Notes
Allowed
Nature ImmunologyPolicy
Preferred server
Notes
Allowed
Nature MedicinePolicy
Preferred server
Notes
Allowed
Nature MethodsPolicy
Preferred server
Notes
Allowed
Nature NeurosciencePolicy
Preferred server
Notes
Policy
Preferred server
Notes
Allowed
NEJMPolicy
Preferred server
Notes
Allowed
NeuronPolicy
Preferred server
Notes
Allowed
Nucleic Acids ResearchPolicy
Preferred server
Notes
Encouraged
PLOS MedicinePolicy
Preferred server
Notes
Encouraged
PLOS ONEPolicy
Preferred server
Notes
Allowed
PNASPolicy
Preferred server
Notes
Allowed
SciencePolicy
Preferred server
Notes
Allowed
Science AdvancesPolicy
Preferred server
Notes
Policy
Preferred server
Notes
Allowed
Scientific ReportsPolicy
Preferred server
Notes
Encouraged
The BMJPolicy
Preferred server
Notes
Encouraged
The EMBO JournalPolicy
Preferred server
Notes
Allowed
The LancetPolicy
Preferred server
Notes
Allowed
The Lancet OncologyPolicy
Preferred server
Notes
| Journal | Policy | Preferred server |
|---|---|---|
| Blood | Allowed | bioRxiv / medRxiv |
| BMC Medicine | Allowed | bioRxiv / medRxiv |
| BMJ Open | Encouraged | medRxiv |
| Brain | Allowed | bioRxiv / medRxiv |
| Cancer Cell | Allowed | bioRxiv / medRxiv |
| Cell | Allowed | bioRxiv / any |
| Cell Host & Microbe | Allowed | bioRxiv |
| Cell Metabolism | Allowed | bioRxiv |
| Cell Reports | Allowed | bioRxiv |
| Cell Stem Cell | Allowed | bioRxiv |
| Circulation | Allowed | medRxiv |
| Circulation Research | Allowed | bioRxiv / medRxiv |
| Current Biology | Allowed | bioRxiv |
| Developmental Cell | Allowed | bioRxiv |
| eLife | Encouraged | bioRxiv / medRxiv |
| European Heart Journal | Allowed | medRxiv / bioRxiv |
| Frontiers in Immunology | Allowed | bioRxiv / any |
| Gastroenterology | Allowed | medRxiv / bioRxiv |
| Genome Biology | Encouraged | bioRxiv |
| GUT | Allowed | medRxiv / bioRxiv |
| Hepatology | Allowed | medRxiv / bioRxiv |
| Immunity | Allowed | bioRxiv |
| JACC | Allowed | medRxiv |
| JAMA | Allowed | medRxiv |
| JAMA Cardiology | Allowed | medRxiv |
| JAMA Oncology | Allowed | medRxiv |
| Journal of Clinical Investigation | Not allowed | – |
| Journal of Clinical Oncology | Allowed | medRxiv |
| Journal of Neuroscience | Allowed | bioRxiv |
| Lancet Infectious Diseases | Allowed | medRxiv |
| Lancet Neurology | Allowed | medRxiv |
| Molecular Cell | Allowed | bioRxiv |
| Molecular Psychiatry | Allowed | bioRxiv / medRxiv |
| Nature | Allowed | bioRxiv / any |
| Nature Biotechnology | Allowed | bioRxiv / ChemRxiv |
| Nature Chemical Biology | Allowed | bioRxiv / ChemRxiv |
| Nature Communications | Allowed | bioRxiv / any |
| Nature Genetics | Allowed | bioRxiv |
| Nature Immunology | Allowed | bioRxiv |
| Nature Medicine | Allowed | bioRxiv / medRxiv |
| Nature Methods | Allowed | bioRxiv |
| Nature Neuroscience | Allowed | bioRxiv |
| Nature Structural & Molecular Biology | Allowed | bioRxiv |
| NEJM | Allowed | medRxiv |
| Neuron | Allowed | bioRxiv |
| Nucleic Acids Research | Allowed | bioRxiv / any |
| PLOS Medicine | Encouraged | medRxiv / bioRxiv |
| PLOS ONE | Encouraged | bioRxiv / any |
| PNAS | Allowed | bioRxiv / any |
| Science | Allowed | bioRxiv / any |
| Science Advances | Allowed | bioRxiv / any |
| Science Translational Medicine | Allowed | bioRxiv / medRxiv |
| Scientific Reports | Allowed | bioRxiv / any |
| The BMJ | Encouraged | medRxiv |
| The EMBO Journal | Encouraged | bioRxiv |
| The Lancet | Allowed | medRxiv preferred |
| The Lancet Oncology | Allowed | medRxiv preferred |
Most researchers post at the same time as or just before journal submission. This establishes priority without delaying the journal submission. Some post earlier to get community feedback before finalizing the manuscript. This works well for computational/methods papers where community scrutiny catches errors quickly.
Don't post if your target journal explicitly prohibits it (currently only JCI in this list) or if you haven't checked the policy. A policy violation can complicate submission.
Most journals that allow preprints ask you to disclose that a preprint exists in the cover letter or submission form. Include the preprint DOI. This is a transparency requirement, not a problem. Editors expect it.
If the manuscript is revised substantially after peer review, update the preprint to reflect the final version. Both bioRxiv and medRxiv allow version updates.
Practical note
Ready to apply this to a real draft?
Use the public submission-readiness path when you already have a manuscript and need a draft-specific signal, not just a general guide.
Best for researchers who want a fast readiness read before deciding whether to revise, retarget, or submit.
Related guides in this collection
Author Rights Guide
Use this when preprint and accepted-manuscript questions turn into rights and embargo questions.
Open Access Guide
Connect preprint strategy to APCs, funder mandates, and journal policies.
Data Sharing Requirements
Plan repository and data-availability steps alongside preprint posting.
Reference Library
Return to the broader publishing reference library for timelines, specs, and policy guides.
No. For almost all journals (56 of the 57 covered here), preprint posting does not constitute prior publication. Journals treat the preprint as a public draft, not a published work. The sole exception in this list is the Journal of Clinical Investigation (JCI), which explicitly prohibits preprint posting before publication. Always confirm on the target journal's current author guidelines.
Use bioRxiv for basic life sciences research: molecular biology, cell biology, genetics, neuroscience, immunology, biochemistry, and genomics. Use medRxiv for clinical medicine, epidemiology, public health, and research involving patient data or health outcomes. When in doubt, check which server your target journal recommends - many (like NEJM and JAMA) specify medRxiv for clinical manuscripts.
No. There is no evidence that preprint posting reduces acceptance rates. Most top journals (Nature, Science, Cell, NEJM, JAMA, Lancet) explicitly allow and some actively encourage preprints. Editors evaluate the manuscript on its scientific merit, not on whether a preprint exists. Some journals - including eLife and PLOS ONE - have formal direct submission pathways from bioRxiv, treating preprint posting as a positive signal.